Adicet Bio, Inc. is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Its lead product candidate, prulacabtagene leucel (prula-cel), targets CD20 and is being developed for autoimmune diseases including lupus nephritis, SLE, systemic sclerosis, and others. The company also advances ADI-212, targeting PSMA for prostate cancer, using CAR engineering, IL-12 armoring, and CRISPR/Cas9 gene editing to enhance solid tumor potency.
expected 2026-12-01
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001720580-26-000008 | EDGAR | 103K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034587 | EDGAR | 122K words |
| 2024-03-19 | 2023-12-31 | 0000950170-24-033482 | EDGAR | 95K words |
| 2023-03-15 | 2022-12-31 | 0000950170-23-008130 | EDGAR | 96K words |
| 2022-03-15 | 2021-12-31 | 0000950170-22-003753 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001564590-21-012664 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010474 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001564590-19-008262 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001564590-18-007150 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001720580-26-000050 | EDGAR | 69K words |
| 2025-11-05 | 2025-09-30 | 0001193125-25-266880 | EDGAR | 71K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104978 | EDGAR | 70K words |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064448 | EDGAR | 66K words |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122253 | EDGAR | 66K words |
| 2024-08-13 | 2024-06-30 | 0000950170-24-095745 | EDGAR | 65K words |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059507 | EDGAR | 57K words |
| 2023-11-08 | 2023-09-30 | 0000950170-23-061128 | EDGAR | 60K words |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040631 | EDGAR | 59K words |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019700 | EDGAR | 57K words |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023230 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016254 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-28 | 0001720580-26-000060 | EDGAR | 4K words |
| 2026-09-08 | 0001720580-26-000056 | EDGAR | 4K words |
| 2026-09-01 | 0001720580-26-000054 | EDGAR | 1K words |
| 2026-08-05 | 0001720580-26-000049 | EDGAR | 2K words |
| 2026-03-12 | 0001720580-26-000006 | EDGAR | 2K words |
| 2026-01-07 | 0001193125-26-005486 | EDGAR | 2K words |
| 2025-12-29 | 0001193125-25-332343 | EDGAR | 1K words |
| 2025-12-19 | 0001193125-25-326784 | EDGAR | 1K words |
| 2025-11-05 | 0001193125-25-266860 | EDGAR | 3K words |
| 2025-10-07 | 0001193125-25-233427 | EDGAR | 1K words |
214 total filings indexed. 183 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001720580 |
| Ticker | ACET |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.adicetbio.com |
| Listed | 2020-09-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ACET (~200 tokens, structured JSON with cryptographic provenance)